LY6E and glioblastoma: Using Kaplan-Meier analysis, we examined overall survival of patients in the TCGA-GBM dataset based on high and low expression of BST2, IFI44, LGALS3BP, LY6E, NOD1, USP18, OAS3, and PARP12 in tumors.